Gut Microbiota Diversity: Wrong Message in Autism, Wrong Architecture in Formation
NCT ID: NCT06662916
Last Updated: 2024-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
320 participants
OBSERVATIONAL
2017-01-01
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dietetic Pattern in Children With Autism Spectrum Disorders
NCT04719923
Intestinal Microbiota, Tryptophan and Autism
NCT03751930
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
NCT06290258
Gut-oral Axis Microbiome in Autism Spectrum Disorders
NCT05830591
Autism Clinical Risk Factors Investigation With Microbiome and Metabolome Profiling
NCT05849233
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
220 ASD cases regularly followed our specific diet
220 individuals who regularly followed our specific diet program for at least 12 months were identified as a study group.
Microbiota-Diversity Enhancing Diet on children with Autism Spectrum Disorder
Microbiota-Diversity Enhancing Diet on Children with ASD (MIND-DASE) suggested that increasing microbiota diversity through dietary interventions can have significant benefits on the neurodevelopmental outcomes of children with ASD
100 ASD cases who did not have diet compliance
100 children with ASD who did not have diet compliance were identified as control group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Microbiota-Diversity Enhancing Diet on children with Autism Spectrum Disorder
Microbiota-Diversity Enhancing Diet on Children with ASD (MIND-DASE) suggested that increasing microbiota diversity through dietary interventions can have significant benefits on the neurodevelopmental outcomes of children with ASD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having continued follow-up in our center at least 12 months regularly
* Being between the ages of 2-18
Exclusion Criteria
* Having an additional chronic disease
* Following a different diet program other than our center
2 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hasan Onal, MD
Prof M.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Basakşehir Cam & Sakura City Hospital, Autism Nutrition and Research Center
Istanbul, Basaksehir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SBUCAMSAKURAEAH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.